135 related articles for article (PubMed ID: 11005098)
21. Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes.
Adams V; Schmid S; Zariwala M; Schmid M; Kleihues P; Briner J; Schäfer R
Anticancer Res; 1999; 19(1A):1-6. PubMed ID: 10226517
[TBL] [Abstract][Full Text] [Related]
22. Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.
Saunders ME; MacKenzie R; Shipman R; Fransen E; Gilbert R; Jordan RC
Clin Cancer Res; 1999 Sep; 5(9):2455-63. PubMed ID: 10499619
[TBL] [Abstract][Full Text] [Related]
23. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
24. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of p53 protein is common in premalignant head and neck lesions.
Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma.
Yamazaki Y; Chiba I; Hirai A; Satoh C; Sakakibara N; Notani K; Iizuka T; Totsuka Y
Head Neck; 2005 Aug; 27(8):676-81. PubMed ID: 15957194
[TBL] [Abstract][Full Text] [Related]
27. Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer.
Gallo O; Chiarelli I; Bianchi S; Calzolari A; Simonetti L; Porfirio B
Clin Cancer Res; 1996 Sep; 2(9):1577-82. PubMed ID: 9816336
[TBL] [Abstract][Full Text] [Related]
28. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.
Hauser U; Balz V; Carey TE; Grénman R; Van Lierop A; Scheckenbach K; Bier H
Head Neck; 2002 Sep; 24(9):868-73. PubMed ID: 12211051
[TBL] [Abstract][Full Text] [Related]
29. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors.
Nees M; Homann N; Discher H; Andl T; Enders C; Herold-Mende C; Schuhmann A; Bosch FX
Cancer Res; 1993 Sep; 53(18):4189-96. PubMed ID: 8364914
[TBL] [Abstract][Full Text] [Related]
30. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
[TBL] [Abstract][Full Text] [Related]
31. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
Ganly I; Soutar DS; Brown R; Kaye SB
Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
[TBL] [Abstract][Full Text] [Related]
32. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB
J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532
[TBL] [Abstract][Full Text] [Related]
33. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
34. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
[TBL] [Abstract][Full Text] [Related]
35. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
36. p16(INK4alpha)/exon 2 mutations in squamous cell carcinoma of the head and neck region.
Lehnerdt G; Fischer M
Acta Otolaryngol; 2006 Apr; 126(4):414-7. PubMed ID: 16608795
[TBL] [Abstract][Full Text] [Related]
37. [Immune response to p53 protein in patients with squamous epithelial carcinoma of the upper aerodigestive tract is independent of p53 point mutation].
Gottschlich S; Maass JD; Görögh T; Lippert BM; Werner JA
Laryngorhinootologie; 1996 May; 75(5):301-5. PubMed ID: 8672215
[TBL] [Abstract][Full Text] [Related]
38. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
[TBL] [Abstract][Full Text] [Related]
39. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
[TBL] [Abstract][Full Text] [Related]
40. p53--master and commander.
Foulkes WD
N Engl J Med; 2007 Dec; 357(25):2539-41. PubMed ID: 18094374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
